Publicacións en colaboración con investigadores/as de Hospital Universitario Nuestra Señora de Candelaria (62)

2024

  1. Comment on “Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease”

    Archivos de Bronconeumologia

  2. Continuity of Care in Chronic Obstructive Pulmonary Disease Exacerbations: Challenges and Priorities

    Archivos de Bronconeumologia

  3. Oxygen therapy could improve survival in patients with early desaturation in the 6-minute walk test: A post hoc analysis

    Respirology

  4. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia

2023

  1. A Novel Figure and Algorithm for the GOLD-ABE Classification: Additional Comments

    Archivos de Bronconeumologia

  2. Alpha-1 antitrypsin deficiency and Pi*S and Pi*Z SERPINA1 variants are associated with asthma exacerbations

    Pulmonology

  3. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

    BMC Health Services Research, Vol. 23, Núm. 1

  4. Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry

    The European respiratory journal

  5. Classification of the Severity of COPD Exacerbations in Hospitalized Patients According to Rome vs GesEPOC Criteria

    Archivos de Bronconeumologia, Vol. 59, Núm. 1, pp. 57-58

  6. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry (Respiratory Research, (2022), 23, 1, (352), 10.1186/s12931-022-02275-4)

    Respiratory Research

  7. Development and validation of a prognostic index (BODEXS90) for mortality in stable chronic obstructive pulmonary disease

    Pulmonology, Vol. 29, Núm. 4, pp. 276-283

  8. Early Desaturation During 6-Minute Walk Test is a Predictor of Mortality in COPD

    Lung, Vol. 201, Núm. 2, pp. 217-224

  9. Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565

  10. Impact of Oral Antidiabetics Agents in the Prevention of COPD Exacerbations

    Archivos de Bronconeumologia

  11. Is it Reasonable to Start Bronchodilator Treatment Before Confirming the Diagnosis of COPD?

    Open Respiratory Archives

  12. Nocturnal Dyspnea During Severe Exacerbations Is Associated With Mortality Risk in COPD

    Respiratory care, Vol. 68, Núm. 3, pp. 413-416

  13. Prevalence, Knowledge and Perceptions of Smoking and Tobacco Products and Vape Among SEPAR Members

    Open Respiratory Archives, Vol. 5, Núm. 4

  14. Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin

    International Journal of COPD, Vol. 18, pp. 1691-1700

  15. Relationship Between the Summation of GesEPOC High-Risk Factors and the Presence of Cardiovascular Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 6, pp. 403-405

  16. Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors

    Journal of Internal Medicine, Vol. 294, Núm. 1, pp. 69-82